Get the Stockscreener App
4.85
0.31%
0.015
After Hours:
4.85
Dogwood Therapeutics Inc stock is traded at $4.85, with a volume of 4,209.
It is up +0.31% in the last 24 hours and down -2.02% over the past month.
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
See More
Previous Close:
$4.835
Open:
$4.79
24h Volume:
4,209
Relative Volume:
0.06
Market Cap:
$9.27M
Revenue:
-
Net Income/Loss:
$-5.73M
P/E Ratio:
-0.7405
EPS:
-6.55
Net Cash Flow:
$-4.13M
1W Performance:
+1.68%
1M Performance:
-2.02%
6M Performance:
-61.17%
1Y Performance:
+0.00%
1-Day Range:
$4.79
$4.89
1-Week Range:
$4.65
$5.07
52-Week Range:
$1.62
$29.28
Dogwood Therapeutics Inc Stock (DWTX) Company Profile
Name
Dogwood Therapeutics Inc
Sector
Industry
Phone
(866) 620-8655
Address
44 MILTON AVENUE, ALPHARETTA
Compare DWTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DWTX
Dogwood Therapeutics Inc
|
4.85 | 9.24M | 0 | -5.73M | -4.13M | -6.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Dogwood Therapeutics Inc Stock (DWTX) Latest News
How high can Dogwood Therapeutics Inc. stock price go in 2025Free Oversold Recovery Opportunity Stocks - Newser
What does recent volatility data suggest for Dogwood Therapeutics Inc.Tactical Trade Setup With Entry Optimizer - Newser
Why Dogwood Therapeutics Inc. is moving todayChart Risk Profile for Capital Preservation - Newser
What makes Dogwood Therapeutics Inc. stock price move sharplyBuy Point Strategy with Profit Protection - Newser
How volatile is Dogwood Therapeutics Inc. stock compared to the marketSwing Trade Forecasts For Smart Trading - jammulinksnews.com
Why is Dogwood Therapeutics Inc. stock attracting strong analyst attentionPost Market Watchlist For Every Investor - jammulinksnews.com
Published on: 2025-07-30 21:51:31 - Newser
Dogwood Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveAI-Based Stock Behavior Forecast Engine - Newser
When is Dogwood Therapeutics Inc. stock expected to show significant growthMarket Forecast Recommendation With Low Risk - jammulinksnews.com
How to read the order book for Dogwood Therapeutics Inc.Short-Term Price Breakout Signal Analysis - Newser
Does Dogwood Therapeutics Inc. stock perform well during market downturnsFree Stock Target Finder For Fast Growth - jammulinksnews.com
What candlestick patterns are forming on Dogwood Therapeutics Inc.AI Model Forecasting Reversal and Breakout Zones - Newser
Chart based analysis of Dogwood Therapeutics Inc. trendsFree News Based Entry Opportunity Alerts - Newser
Published on: 2025-07-30 03:04:48 - Newser
Published on: 2025-07-30 00:01:23 - metal.it
Dogwood Therapeutics Inc. Breakout Confirmed by Volume MetricsConsistent Gain Investment Strategies Emerge - metal.it
Sector ETF Data Correlates with Strength in Dogwood Therapeutics Inc.Short Term Buy Zone Stock Alerts Signal Entry - metal.it
Are Bears Losing Grip on Dogwood Therapeutics Inc.High Conviction Intraday Stock Signals Detected - metal.it
Regression Model Predicts Rangebound Movement in Dogwood Therapeutics Inc.Weekly Top Gainers Forecast Watchlist Released - metal.it
Quant Funds Rotate Into Dogwood Therapeutics Inc. StockAI Driven Buy Alert Trade Blueprint Released - metal.it
Quant Models Detect Momentum Reversal in Dogwood Therapeutics Inc.Low Volatility Stable Growth Picks Rank High - beatles.ru
Published on: 2025-07-28 15:28:54 - metal.it
Applying chart zones and confluence areas to Dogwood Therapeutics Inc.Free Risk Controlled Short Term Trade Plans - Newser
How to read the order book for Dogwood Therapeutics Inc. Predictable Return Strategy with AI Support - Newser
What are the latest earnings results for Dogwood Therapeutics Inc.Build a portfolio for long-term financial success - jammulinksnews.com
Should I hold or sell Dogwood Therapeutics Inc. stock in 2025Proven strategies for superior portfolio growth - jammulinksnews.com
How Dogwood Therapeutics Inc. stock performs during market volatilityMarket Downturn Defense Strategy Analysis - Newser
What is Dogwood Therapeutics Inc. company’s growth strategyAccess high-quality stock research instantly - jammulinksnews.com
Published on: 2025-07-27 22:24:20 - jammulinksnews.com
Top Risks to Consider Before Buying Dogwood Therapeutics Inc. StockFree Smart Money Stock Analysis - Newser
What are analysts’ price targets for Dogwood Therapeutics Inc. in the next 12 monthsAchieve rapid portfolio appreciation today - jammulinksnews.com
What makes Dogwood Therapeutics Inc. stock attractive to long term investorsBreakthrough profit margins - jammulinksnews.com
Dogwood Therapeutics Inc Stock (DWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):